Press Ctrl + D to add me to your bookmarks
Add to Google
Latest news headlines : China still lags behind in R&D and production of pharmaceutical excipients - Chinese Exports of western medicines see sustainable and high-speed growth in first half of 2008 - Chinese API manufacturers eying preparation market -
  Print

Solvay Advanced Polymers Commissions New PEEK Plant in India

By Solvay
Monday, 21 April 2008
Solvay Advanced Polymers, makers of more plastics with more performance, announced today that it has commissioned its new commercial PEEK (polyetheretherketone) facility at its site in Panoli, India. The new facility is now in its start-up phase and is running initial commercial production.
The plant is capable of producing 500 metric tons annually, and is scalable in design to double capacity to meet demand for Solvay Advanced Polymers’ KetaSpire® PEEK and AvaSpire® modified PEEK products.

“We’re very pleased to arrive at this significant milestone with our new PEEK unit”, commented George Corbin, President & CEO of Solvay Advanced Polymers . “Even more importantly, I take a great deal of personal pride in the team that has successfully brought us to this point – on time, under budget and with no injuries or loss-time incidents. It’s testament to a tremendous amount
of hours and effort from a lot of people from around the world, and especially the entire team at our Panoli site."

Since launching its Spire® line in late 2006, Solvay Advanced Polymers has been supplying KetaSpire PEEK and AvaSpire modified PEEK from its semi-commercial unit located in Alpharetta, Georgia. With today’s announcement, the company has completed a significant step in its strategic entrance into the PEEK market. In the past 18 months, Solvay Advanced Polymers has been seeding and specifying its KetaSpire PEEK and AvaSpire modified PEEK into a range of markets and applications from its semi-commercial facility. The new commercial facility in Panoli will now support and expand upon those opportunities.



“When we announced our intention to enter into the PEEK market it was part of a comprehensive strategy
built upon an entire family of ultra-performance products,” explained Vincenzo Morici, Solvay Group’s Specialty Polymers Business General Manager. “Today’s announcement continues that strategic vision of supplying our customers with more polymeric options to solve their top design challenges.”

KetaSpire PEEK and AvaSpire modified PEEK are highly-prized ultra polymers that offer design engineers best-in-class chemical resistance and mechanical properties, including strength, stiffness and ease of processing. This combination of performance attributes makes PEEK an ideal polymer for applications in aerospace, automotive, friction and wear components, healthcare, oil exploration and production, and semi-conductors, among others. KetaSpire PEEK is also available in film form for specialized applications.
______________________________

Want to read more?
______________________________
About Solvay Pharmaceuticals
Latest News Headlines :
China still lags behind in R&D and production of pharmaceutical excipients
Chinese Exports of western medicines see sustainable and high-speed growth in first half of 2008
Chinese API manufacturers eying preparation market
Latest Press Releases Headlines :
Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
Donation of Emergency Response Wireless Network (ERWN) equipment serves
China Biologic Products Announces Second Quarter 2008 Results Conference Call
Product of the month :
Advantia Coating Systems for pharmaceuticals
 
NEW! Send your Press Release for publication
Related Pharmaceutical & Lifesciences websites : Pharmaceutical Manufacturing News | Asia Lifesciences
Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing
QA/QC | Pharmaceutical Strategy | Drug Discovery | Biotechnology | Clincal Development
Subscribe Unsubscribe Advertise Privacy Statement Copyright
Intelligent Publishing MediaContact - 21, rue du Grand Prieuré – 75012 Paris FRANCE